NASDAQ:RXRX (Recursion Pharmaceuticals, Inc.)
About RXRX
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world's largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale - up to millions of wet lab experiments weekly - and massive computational scale - owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective.
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) Latest News
Investing Articles
Could this Nvidia-backed growth stock be a millionaire-maker at $10?
Investing Articles
Nvidia and a FTSE 100 fund own a 10% stake in this $8 artificial intelligence (AI) stock